Earnings digests and industry comparisons for Japan's biggest listed companies.
640 reports(page 49 of 54)
Sumitomo Pharma reported a 19.9% jump in revenue to ¥129.5 billion for the first quarter of its fiscal year ending March 2027, but core operating profit fell 11.0% to ¥18.1 billion. The bottom line got a boost from a sharp swing to foreign exchange gains, lifting net profit 51.7% to ¥17.0 billion.
FY2027 Q1 (Apr-Jun 2026)
Sekisui Chemical reported record revenue, operating profit and ordinary profit for the April-June quarter, driven by price pass-through and robust electronics demand, though net income slipped 2.7% on restructuring charges.
Q1 FY2027 (Apr-Jun 2026)
Daicel reported first-quarter revenue of ¥152.38 billion, up 9.4%, and operating profit of ¥14.04 billion, up 7.7%, as AI-related demand boosted high-performance polymers. Net income slipped 2.7% to ¥9.36 billion on prior-year one-offs, yet the full-year net profit outlook of ¥32 billion represents a 2.1-fold increase.
Q1 FY2027 (April-June 2026)
Mitsubishi Chemical posted stellar Q1 FY2027 results, with revenue up 14.0% to ¥1,004.2 billion, core operating profit more than doubling to ¥114.1 billion, and net income surging 194.0% to ¥57.7 billion. Gains were driven by semiconductor demand, higher MMA prices, and inventory valuation profits from rising naphtha, leading the company to lift its first-half outlook.
Q1 FY2027 (Apr-Jun 2026)
Asahi Kasei's Q1 FY2027 revenue rose 11.9% to ¥826.1bn, operating profit jumped 51.5% to ¥81.3bn, and net income surged 172.7% to ¥53.8bn. All segments posted higher sales and profit, with Materials driving the recovery and Healthcare benefiting from M&A.
Q1 FY2027 (Apr-Jun 2026)
Toyota Boshoku's revenue rose 10.1% to ¥528 billion in Q1 FY2027, but operating profit fell 15.1% to ¥15.8 billion and net income dropped 18.9% to ¥8.7 billion, weighed by China's slowdown and higher costs. The company also revised its full-year forecast.
Q1 FY2027 (April-June 2026)
ZOZO said revenue for the fiscal first quarter ended June rose 3.9% to ¥56.1 billion, while operating profit advanced 5.7% to ¥17.9 billion. The Japanese fashion e-commerce firm also announced a ¥30 billion share buyback and maintained its full-year forecasts.
Q1 FY2027 (April-June 2026)
Japan Tobacco Inc. (JT) reported a 17.7% year-on-year increase in revenue to ¥1.986 trillion for the first half of fiscal 2026, driven by currency tailwinds and price hikes in its tobacco business. Operating profit surged 29.0% to ¥644.9 billion, while net income climbed 35.0% to ¥431.8 billion. The company raised its full-year earnings forecast, citing sustained momentum.
H1 FY2026 (Jan–Jun 2026)
Toyo Suisan reported a 23.4% jump in first-quarter operating profit for FY2027, driven by strong overseas instant noodle performance, as revenue grew 7.8% to ¥135.67 billion. Net income rose 19.5% to ¥18.23 billion, while the operating margin widened to 16.6% from 14.5%.
Q1 FY2027 (Apr-Jun 2026)
Yakult posted a 3.3% revenue increase to ¥120,463 million for the first quarter of FY2027, yet operating profit slid 7.5% to ¥10,088 million as robust overseas growth was offset by domestic weakness. Net income attributable to parent company shareholders surged 17.2% to ¥13,591 million thanks to gains from sales of investment securities.
Q1 FY2027 (April - June 2026)
Kandenko posted a 4.5% drop in Q1 FY2027 revenue to ¥158.0 billion, while operating profit climbed 12.8% to ¥19.7 billion on better margins. Net income rose 4.2% to ¥13.2 billion, and new orders grew 11.2%.
Q1 FY2027 (Apr-Jun 2026)
Daito Trust’s Q1 FY2027 revenue edged up 0.4% to ¥480.1bn, operating profit rose 15.5% to ¥39.3bn, but a ¥4.2bn investment valuation loss dragged net profit down 1.8% to ¥23.6bn.
Q1 FY2027 (Apr-Jun 2026)
